208 related articles for article (PubMed ID: 33256852)
1. Whole blood DNA methylation aging markers predict colorectal cancer survival: a prospective cohort study.
Gào X; Zhang Y; Boakye D; Li X; Chang-Claude J; Hoffmeister M; Brenner H
Clin Epigenetics; 2020 Nov; 12(1):184. PubMed ID: 33256852
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer.
Beynon RA; Ingle SM; Langdon R; May M; Ness A; Martin RM; Suderman M; Ingarfield K; Marioni RE; McCartney DL; Waterboer T; Pawlita M; Relton C; Smith GD; Richmond RC
Clin Epigenetics; 2022 Jan; 14(1):1. PubMed ID: 34980250
[TBL] [Abstract][Full Text] [Related]
3. Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study.
Li X; Zhang Y; Gào X; Holleczek B; Schöttker B; Brenner H
EBioMedicine; 2021 Dec; 74():103686. PubMed ID: 34808433
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation Age and Physical and Cognitive Aging.
Maddock J; Castillo-Fernandez J; Wong A; Cooper R; Richards M; Ong KK; Ploubidis GB; Goodman A; Kuh D; Bell JT; Hardy R
J Gerontol A Biol Sci Med Sci; 2020 Feb; 75(3):504-511. PubMed ID: 31630156
[TBL] [Abstract][Full Text] [Related]
5. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract][Full Text] [Related]
6. Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study.
Li X; Schöttker B; Holleczek B; Brenner H
EBioMedicine; 2022 Jul; 81():104083. PubMed ID: 35636319
[TBL] [Abstract][Full Text] [Related]
7. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
[TBL] [Abstract][Full Text] [Related]
8. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
9. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
Gündert M; Edelmann D; Benner A; Jansen L; Jia M; Walter V; Knebel P; Herpel E; Chang-Claude J; Hoffmeister M; Brenner H; Burwinkel B
Gut; 2019 Jan; 68(1):101-110. PubMed ID: 29101262
[TBL] [Abstract][Full Text] [Related]
11. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
[TBL] [Abstract][Full Text] [Related]
12. CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.
Kim CH; Huh JW; Kim HR; Kim YJ
J Gastroenterol Hepatol; 2017 Aug; 32(8):1469-1474. PubMed ID: 28087988
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
14. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
Raut JR; Guan Z; Schrotz-King P; Brenner H
Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
[TBL] [Abstract][Full Text] [Related]
15. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
[TBL] [Abstract][Full Text] [Related]
16. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
18. A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.
Onwuka JU; Li D; Liu Y; Huang H; Xu J; Liu Y; Zhang Y; Zhao Y
BMC Cancer; 2020 Jul; 20(1):692. PubMed ID: 32711505
[TBL] [Abstract][Full Text] [Related]
19. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
20. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients.
Boakye D; Jansen L; Schöttker B; Jansen EHJM; Schneider M; Halama N; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
Int J Cancer; 2020 Nov; 147(9):2373-2386. PubMed ID: 32319674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
